반려동물 감염병 진단 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 동물 유형별, 제품 유형별, 감염 유형별, 기술별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Companion Animal Infectious Disease Diagnostics Market Summary

The global companion animal infectious disease diagnostics market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.42 billion by 2033, growing at a CAGR of 7.44% from 2025 to 2033. The market continues to grow steadily, fueled by increasing pet ownership, a rising incidence of infectious diseases, and ongoing technological advancements in diagnostic tools.

Millennials represent the largest segment of pet owners, with around 66% of U.S. households owning a pet. As of 2024, approximately 65.1 million U.S. households have a dog, while 46.5 million own a cat. Moreover, the growing prevalence of infectious diseases among pets is a key driver of the companion animal infectious disease diagnostics industry, as it heightens the demand for timely and precise detection to help prevent outbreaks, lower mortality rates, and protect public health. For example, as reported by Sploot in January 2025, avian influenza (bird flu), an infectious disease caused by various influenza virus strains, experienced a multi-state outbreak in late 2024 and early 2025. The H5N1 strain has impacted commercial and backyard flocks, wild birds, and has also been found to infect humans, cats, and dogs.

Similarly, Canine influenza virus (CIV), commonly known as canine flu, is currently undergoing an outbreak in the U.S., driven by its highly contagious nature. The two prevalent strains, H3N8 and H3N2, are both influenza A viruses that spread swiftly through respiratory droplets, direct contact, and contaminated surfaces such as bowls, collars, or kennels. This rapid transmission, especially in high-density areas like shelters, daycare centers, and boarding facilities, underscores the urgent need for early and accurate detection.

As a result, the outbreak is significantly fueling growth in the companion animal infectious disease diagnostics industry. Veterinarians and pet healthcare providers are increasingly adopting advanced diagnostic tools, such as PCR-based tests and rapid antigen detection kits, to quickly identify infected animals, implement isolation protocols, and curb the spread of the virus. The heightened awareness among pet owners about the risks of canine flu and the necessity of timely intervention is further boosting demand for diagnostic services, positioning disease detection as a critical component of disease control and overall pet health management.

Furthermore, a key factor amplifying this demand is the generational shift in pet ownership behavior. Millennials and Gen Z now make up the majority of pet parents and are more likely to treat their animals as family members, prioritizing preventive healthcare and wellness diagnostics. According to IDEXX's 2024 survey, 73% of Millennials and 71% of Gen Z pet owners agree to at least annual wellness diagnostics for their pets. These younger owners are also more likely to adopt younger animals with 48% of Gen Z and 37% of Millennials owning dogs under two years old-fostering a long-term approach to health monitoring that starts early in the pet's life and continues throughout its lifespan.

Global Companion Animal Infectious Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion animal infectious disease diagnostics market report based on animal type, product, technology, Infection type, end-use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables, Reagents & Kits
• Equipment & Instruments
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Immunodiagnostics
  • Lateral Flow Assays
  • ELISA Test
  • Others
• Molecular Diagnostic
  • Polymerase Chain Reaction (PCR) Tests
  • Microarrays
  • Others
• Others
• Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
• Canine
• Feline
• Equine
• Others
• Infection Type Outlook (Revenue, USD Million, 2021 - 2033)
• Bacterial
• Viral
• Parasitic
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals and Clinics
• Veterinary Reference Laboratories
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Companion animal infectious disease diagnostics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of infectious diseases in animals
    • 3.2.1.2. Rising medicalization rate
    • 3.2.1.3. Increasing pet health expenditure
    • 3.2.1.4. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of standardized regulations
    • 3.2.2.2. Lack of awareness in developing economies
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Companion animal infectious disease diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Disease Outbreak Analysis
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. Companion Animal Infectious Disease Diagnostics Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Companion animal infectious disease diagnostics Market: Animal type Movement Analysis
• 4.3. Companion animal infectious disease diagnostics Market Size & Trend Analysis, by animal type, 2021 to 2033 (USD Million)
• 4.4. Canine
  • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Feline
  • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Equine
  • 4.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion animal infectious disease diagnostics Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Companion animal infectious disease diagnostics Market: Technology Movement Analysis
• 5.3. Companion animal infectious disease diagnostics Market Size & Trend Analysis, by technology, 2021 to 2033 (USD Million)
• 5.4. Immunodiagnostics
  • 5.4.1. Immunodiagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Lateral Flow Assays
    • 5.4.2.1. Lateral Flow Assays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. ELISA Test
    • 5.4.3.1. ELISA Test Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Molecular Diagnostic
  • 5.5.1. Molecular Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Polymerase Chain Reaction (PCR) Tests
    • 5.5.2.1. Polymerase Chain Reaction (PCR) Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Microarrays
    • 5.5.3.1. Microarrays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Others
    • 5.5.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion animal infectious disease diagnostics Market: By Product Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Companion animal infectious disease diagnostics Market: By Product Movement Analysis
• 6.3. Companion animal infectious disease diagnostics Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
  • 6.3.1. Consumables, Reagents & Kits
    • 6.3.1.1. Consumables, Reagents & Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Equipment & Instruments
    • 6.3.2.1. Equipment & Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion animal infectious disease diagnostics Market: By Infection Type Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Companion animal infectious disease diagnostics Market: By Infection Type Movement Analysis
• 7.3. Companion animal infectious disease diagnostics Market Size & Trend Analysis, by Infection type, 2021 to 2033 (USD Million)
  • 7.3.1. Bacterial
    • 7.3.1.1. Bacterial Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Viral
    • 7.3.2.1. Viral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Parasitic
    • 7.3.3.1. Parasitic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Others
    • 7.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion animal infectious disease diagnostics Market: By End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Companion animal infectious disease diagnostics Market: By End Use Movement Analysis
• 8.3. Companion animal infectious disease diagnostics Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 8.3.1. Veterinary Hospitals and Clinics
    • 8.3.1.1. Veterinary Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. Veterinary Reference Laboratories
    • 8.3.2.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Companion animal infectious disease diagnostics Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Companion animal infectious disease diagnostics Market Share, By Region, 2024 & 2033 (USD Million)
• 9.3. Regional Outlook
• 9.4. North America
  • 9.4.1. North America Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. U.S. Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Canada Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Mexico Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. UK Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Germany Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. France Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Italy Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Spain Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Denmark
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Denmark Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Sweden Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.9. Norway
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Norway Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Japan Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. China Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. India Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Australia Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. South Korea Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Thailand Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Brazil Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Argentina Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.8. Middle East & Africa
  • 9.8.1. Middle East & Africa Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. South Africa Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Saudi Arabia Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. UAE Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Kuwait Companion animal infectious disease diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profiles
  • 10.3.1. IDEXX Laboratories Inc.
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Zoetis Services LLC.
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Antech Diagnostics, Inc.
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Thermo Fisher Scientific, Inc
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Virbac
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. bioMerieux SA
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Neogen Corporation
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. IDVet
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Agrolabo S.p.A.
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Bio-Rad Laboratories, Inc
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Product launch
  • 10.4.4. Others
• 10.5. List of other key players